Conversation with The Cancer Letter Infections are a major cause of death in patients treated with CAR T-cell therapyMeta-analysis focused on causes of death, excluding relapse, recurrence July 12, 2024Vol.50 No.28By Matthew Bin Han Ong
Cancer History Project “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor July 12, 2024Vol.50 No.28By McKenzie Prillaman
In Brief Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center July 12, 2024Vol.50 No.28
In Brief Glen Barber named director of Center for Innate Immunity and Inflammation at Ohio State’s Pelotonia Institute for Immuno-Oncology July 12, 2024Vol.50 No.28
In Brief UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy July 12, 2024Vol.50 No.28
In Brief Sanaz Memarzadeh receives $4.1M to develop immune therapies for ovarian cancer July 12, 2024Vol.50 No.28
